Cita APA

Contador Muñana, J. M., Vargas Martinez, A. M., Sánchez Valle, R., Trapero Bertran, M., & Lladó Plarrumaní, A. (2022). Cost-effectiveness of Alzheimer's disease CSF biomarkers and amyloid-PET in early-onset cognitive impairment diagnosis.

Citación estilo Chicago

Contador Muñana, José Miguel, A. M. Vargas Martinez, Raquel Sánchez Valle, M. Trapero Bertran, y Albert Lladó Plarrumaní. Cost-effectiveness of Alzheimer's Disease CSF Biomarkers and Amyloid-PET in Early-onset Cognitive Impairment Diagnosis. 2022.

Cita MLA

Contador Muñana, José Miguel, et al. Cost-effectiveness of Alzheimer's Disease CSF Biomarkers and Amyloid-PET in Early-onset Cognitive Impairment Diagnosis. 2022.